TABLE 3.

Hub genes with prognostic potential and the association between their expression and CRC patient survival.

Gene name	Dataset	Endpoint	Cohort	Probe ID	N	COX P-value	HR [95% CI-low CI-upp]	Prognosis
NUSAP1	GSE12945	Overall survival	Berlin	218039_at	62	0.042761	3.84 [1.04–14.12]	Poorer
NUSAP1	GSE12945	Disease-free survival	Berlin	219978_s_at	51	0.01814	34.78 [1.83–660.48]	Poorer
NUSAP1	GSE12945	Overall survival	Berlin	219978_s_at	62	0.000504	34.32 [4.68–251.59]	Poorer
CCL28	GSE17536	Disease-free survival	MCC	224240_s_at	145	0.028541	0.49 [0.25–0.93]	Better
CCL28	GSE14333	Disease-free survival	Melbourne	224027_at	226	0.034875	0.82 [0.68–0.99]	Better
CCL28	GSE14333	Disease-free survival	Melbourne	224240_s_at	226	0.010374	0.66 [0.48–0.91]	Better
GPR15	GSE17537	Disease-free survival	VMC	208524_at	55	0.029864	0.08 [0.01–0.79]	Better
GPR15	GSE17537	Disease-specific survival	VMC	208524_at	49	0.043031	0.08 [0.01–0.92]	Better
PNOC	GSE17536	Disease-specific survival	MCC	205901_at	177	0.02132	0.30 [0.11–0.84]	Better
PNOC	GSE17536	Overall survival	MCC	205901_at	177	0.015574	0.34 [0.14–0.82]	Better